Regulations & Policy
Govt to close two pharma PSUs, disinvest other three
IMT News Desk
Govt to close two pharma PSUs, disinvest other three
IMT News Desk
The government has also decided to strategically disinvest HAL, BCPL and KAPL
The government has decided to close two pharma public sector undertakings and disinvest the other three, the Parliament was informed.
"The Department of Pharmaceuticals has five public sector undertakings (PSUs). Out of the five PSUs, the government has decided to close two pharma PSUs, namely Indian Drugs & Pharmaceuticals Ltd (IDPL) and Rajasthan Drugs & Pharmaceuticals Ltd (RDPL)," Minister of Chemicals and Fertilisers DV Sadananda Gowda said in response to a question in the Lok Sabha.
The government has also decided to strategically disinvest the other three -- Hindustan Antibiotics Ltd (HAL), Bengal Chemicals & Pharmaceuticals Ltd (BCPL), and Karnataka Antibiotics & Pharmaceutical Ltd (KAPL), he added.
The government has offered voluntary retirement benefits to all employees of IDPL and RDPL, Gowda said.
"However, the Committee of Ministers constituted on September 9, 2019, will take necessary decisions to closure/strategic sale of the pharma public sector undertakings, including the sale of assets and clearance of outstanding liabilities," he added.
Recommended
MSN Laboratories partners with Government of Telangana
November 29, 2024
OPPI Annual Summit sets forth vision for India's healthcare evolution
November 29, 2024